Cargando…

Outcomes of fertility preservation treatments in patients with endometrial cancer with different molecular classifications based on an NGS panel

BACKGROUND: The molecular classification of endometrial cancer has previously been shown to be associated with clinical outcomes. However, there are insufficient data to support the routine use of molecular classification for the treatment of patients seeking fertility preservation. METHODS: Here, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yan, Zhao, Mingming, Zhang, Li, Wang, Tianyou, Wang, Bo, Xue, Yu, Xu, Zhiying, Shao, Wenyu, Chen, Xiaojun, Wang, Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665890/ https://www.ncbi.nlm.nih.gov/pubmed/38023131 http://dx.doi.org/10.3389/fonc.2023.1282356

Ejemplares similares

The Advance and Correlation of KRAS Mutation With the Fertility-Preservation Treatment of Endometrial Cancer in the Background of Molecular Classification Application
por: Yu, KeXuan, et al.
Publicado: (2021)

A new strategy in molecular typing: the accuracy of an NGS panel for the molecular classification of endometrial cancers
por: Li, Yang, et al.
Publicado: (2022)

Clinical implications of morular metaplasia in fertility-preserving treatment for atypical endometrial hyperplasia and early endometrial carcinoma patients
por: Wu, Pengfei, et al.
Publicado: (2022)

Molecular Classification in Patients With Endometrial Cancer After Fertility-Preserving Treatment: Application of ProMisE Classifier and Combination of Prognostic Evidence
por: Ran, Xuting, et al.
Publicado: (2022)

Insulin Resistance and Metabolic Syndrome Increase the Risk of Relapse For Fertility Preserving Treatment in Atypical Endometrial Hyperplasia and Early Endometrial Cancer Patients
por: Li, Xingchen, et al.
Publicado: (2021)

Prognostic classification of endometrial cancer using a molecular approach based on a twelve-gene NGS panel
por: López-Reig, Raquel, et al.
Publicado: (2019)

Copy number variants landscape of multiple cancers and clinical applications based on NGS gene panel
por: Yan, Kangpeng, et al.
Publicado: (2023)

Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective, open-label, randomized controlled phase II trial (ClinicalTrials.gov NCT03241914)
por: Xu, Zhiying, et al.
Publicado: (2022)

Maintenance Therapy Can Improve the Oncologic Prognosis and Obstetrical Outcome of Patients With Atypical Endometrial Hyperplasia and Endometrial Cancer After Fertility-Preserving Treatment: A Multicenter Retrospective Study
por: He, Yijiao, et al.
Publicado: (2021)

Molecular classification grade 3 endometrial endometrioid carcinoma using a next-generation sequencing–based gene panel
por: Li, Ling, et al.
Publicado: (2022)

A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic Applications
por: Tirrò, Elena, et al.
Publicado: (2022)

Fertility-Sparing Treatment for Endometrial Cancer or Atypical Endometrial Hyperplasia Patients With Obesity
por: Chen, Junyu, et al.
Publicado: (2022)

Application of NGS molecular classification in the diagnosis of endometrial carcinoma: A supplement to traditional pathological diagnosis
por: Rao, Qunxian, et al.
Publicado: (2022)

PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia
por: Xue, Yu, et al.
Publicado: (2023)

Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing Therapy
por: Chen, Junyu, et al.
Publicado: (2021)

Effect and Management of Excess Weight in the Context of Fertility-Sparing Treatments in Patients With Atypical Endometrial Hyperplasia and Endometrial Cancer: Eight-Year Experience of 227 Cases
por: Shan, Ying, et al.
Publicado: (2021)

Fertility Preservation in Endometrial Cancer—Treatment and Molecular Aspects
por: Schubert, Melanie, et al.
Publicado: (2023)

Editorial: Fertility-preserving and fertility-sparing treatment approaches in gynecologic malignancies
por: Raimondo, Diego, et al.
Publicado: (2023)

Fertility preserving management of early endometrial cancer in a patient cohort at the department of women’s health at the university of Tuebingen
por: Andress, Jürgen, et al.
Publicado: (2021)

Fertility-preserving treatment outcome in endometrial cancer or atypical hyperplasia patients with polycystic ovary syndrome
por: Wang, Lulu, et al.
Publicado: (2021)

The role of TCGA molecular classification in clear cell endometrial carcinoma
por: Tang, Xinyue, et al.
Publicado: (2023)

Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design
por: Aguilera-Diaz, Almudena, et al.
Publicado: (2020)

The Perspectives of Fertility Preservation in Women with Endometrial Cancer
por: Knez, Jure, et al.
Publicado: (2021)

A Micro-Costing Study of Screening for Lynch Syndrome-Associated Pathogenic Variants in an Unselected Endometrial Cancer Population: Cheap as NGS Chips?
por: Ryan, Neil A. J., et al.
Publicado: (2019)

Case report: Conservative treatment for fertility preservation in a woman with hemoperitoneum due to an invasive mole
por: Xu, Linjuan, et al.
Publicado: (2022)

Fertility-preserving treatment in women with early endometrial cancer: the Chinese experience
por: Wang, Yao, et al.
Publicado: (2018)

MRI-Based Radiomics Nomogram for Selecting Ovarian Preservation Treatment in Patients With Early-Stage Endometrial Cancer
por: Yan, Bi Cong, et al.
Publicado: (2021)

Fertility-preservation in endometrial cancer: is it safe? Review of the literature
por: Carneiro, Márcia Mendonça, et al.
Publicado: (2016)

Fertility preservation in women with cervical, endometrial or ovarian cancers
por: Feichtinger, Michael, et al.
Publicado: (2016)

Fertility-Sparing Treatment in Young Patients With Grade 2 Presumed Stage IA Endometrioid Endometrial Adenocarcinoma
por: Yu, Mei, et al.
Publicado: (2020)

An Efficacious Endometrial Sampler for Screening Endometrial Cancer
por: Han, Lu, et al.
Publicado: (2019)

Validation of Molecular Typing for Endometrial Screening Test That Predicts Benign and Malignant Lesions
por: Tuo, Xiaoqian, et al.
Publicado: (2019)

Fertility preservation in patients with uterus didelphys and endometrial carcinoma: a case report
por: Yu, Jiao, et al.
Publicado: (2021)

Validation of an NGS mutation detection panel for melanoma
por: Reiman, Anne, et al.
Publicado: (2017)

Key considerations for comprehensive validation of an RNA fusion NGS panel
por: Barua, Subit, et al.
Publicado: (2020)

Fertility Preservation: A Key Survivorship Issue for Young Women with Cancer
por: Angarita, Ana Milena, et al.
Publicado: (2016)

Fertility Preservation in Cancer Patients During the Coronavirus (COVID-19) Pandemic
por: Dellino, Miriam, et al.
Publicado: (2020)

Analysis of Factors Associated With Recurrence of Early-Stage Endometrial Carcinoma and Atypical Endometrial Hyperplasia in Infertile Women After In Vitro Fertilization Treatment
por: Guo, Yaxing, et al.
Publicado: (2022)

Oncological outcomes in fertility-sparing treatment in stage IA-G2 endometrial cancer
por: Ronsini, Carlo, et al.
Publicado: (2022)

Cancer, Fertility and Me: Developing and Testing a Novel Fertility Preservation Patient Decision Aid to Support Women at Risk of Losing Their Fertility Because of Cancer Treatment
por: Jones, Georgina L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mqao0gsd5pj6o52tk4gsf6h126